Characterization of novel VIM carbapenemase, VIM-38, and first detection of GES-5 carbapenem-hydrolyzing β-lactamases in Pseudomonas aeruginosa in Turkey
Tài liệu tham khảo
Bahar, 2004, Detection of VIM-5 metallo-beta-lactamase in a Pseudomonas aeruginosa clinical isolate from Turkey, J Antimicrob Chemother, 54, 282, 10.1093/jac/dkh321
Bonnin, 2013, Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii in Kuwait, Antimicrob Agents Chemother, 57, 183, 10.1128/AAC.01384-12
Celenza, 2006, Spread of blaCTX-M-type and blaPER-2 b-lactamase genes in clinical isolates from Bolivian hospitals, J Antimicrob Chemother, 57, 975, 10.1093/jac/dkl055
Chihara, 2011, First case of New Delhi metallo-beta-lactamase 1-producing Escherichia coli infection in Japan, Clin Infect Dis, 52, 153, 10.1093/cid/ciq054
Cicek, 2013, OXA- and GES-type b-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital, Clin Microbiol Infect, 10.1111/1469-0691.12338
Cicek, 2013, Determination of a novel integron-located variant (blaOXA-320) of Class Db-lactamase in Proteus mirabilis, J Basic Microbiol, 10.1002/jobm.201300264
Cicek, 2013, Nationwide study of Escherichia coli producing extended-spectrum β-lactamases TEM, SHV and CTX-M in Turkey, J Antibiot
Clinical and Laboratory Standards Institute (CLSI), 2013
Cornaglia, 2011, Metallo-β-lactamases: a last frontier for β-lactams?, Lancet Infect Dis, 11, 381, 10.1016/S1473-3099(11)70056-1
Gacar, 2005, Genetic and enzymatic properties of metallo-beta-lactamase VIM-5 from a clinical isolate of Enterobacter cloacae, Antimicrob Agents Chemother, 49, 4400, 10.1128/AAC.49.10.4400-4403.2005
Gaynes, 2005, Overview of nosocomial infections caused by gram-negative bacilli, Clin Infect Dis, 41, 848, 10.1086/432803
Jeon, 2005, Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 β-lactamase in Korea, J Clin Microbiol, 43, 2241, 10.1128/JCM.43.5.2241-2245.2005
Labuschagne, 2008, Emergence of class 1 integron-associated GES-5 and GES-5-like extended-spectrum beta-lactamases in clinical isolates of Pseudomonas aeruginosa in South Africa, Int J Antimicrob Agents, 31, 527, 10.1016/j.ijantimicag.2008.01.020
Midilli, 2003, A novel metallo-β-lactamase (VIM-5) from a clinical isolate of Klebsiella pneumoniae, 275
Moubareck, 2009, GES-11, a novel integron-associated GES variant in Acinetobacter baumannii, Antimicrob Agents Chemother, 58, 3579, 10.1128/AAC.00072-09
Nordmann, 2002, Emerging carbapenemases in Gram-negative aerobes, Clin Microbiol Infect, 8, 321, 10.1046/j.1469-0691.2002.00401.x
Nordmann, 2011, The emerging NDM carbapenemases, Trends Microbiol, 19, 588, 10.1016/j.tim.2011.09.005
Ozgumus, 2007, Molecular epidemiology of clinical Pseudomonas aeruginosa isolates carrying IMP-1 metallo-beta-lactamase gene in a university hospital in Turkey, Microb Drug Resist, 13, 191, 10.1089/mdr.2007.748
Picão, 2009, Diversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil, Antimicrob Agents Chemother, 53, 3908, 10.1128/AAC.00453-09
Poirel, 2012, Genetic support and diversity of acquired extended-spectrum β-lactamases in Gram-negative rods, Infect Genet Evol, 12, 883, 10.1016/j.meegid.2012.02.008
Viedma, 2009, Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain, Antimicrob Agents Chemother, 53, 4930, 10.1128/AAC.00900-09
Wang, 2006, A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase, J Antimicrob Chemother, 57, 1261, 10.1093/jac/dkl116
Woodford, 2006, Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp, Int J Antimicrob Agent, 27, 351, 10.1016/j.ijantimicag.2006.01.004
Xu, 2005, Rapid and simple detection of blaCTX-M genes by multiplex PCR assay, J Med Microbiol, 54, 1183, 10.1099/jmm.0.46160-0
Yakupogullari, 2008, Multidrug-resistant Pseudomonas aeruginosa isolate co-expressing extended-spectrum beta-lactamase PER-1 and metallo-beta-lactamase VIM-2 from Turkey, J Antimicrob Chemother, 61, 221, 10.1093/jac/dkm420